News and Trends 27 Sep 2018 Update: Series A Boost Pushes Belgian Microbiome Spin-Off Forward Update (27/09/2018): New investment from Dutch venture capital fund Innovation Industries brings A-Mansia’s Series A round up to €18M. The company’s first human study of the effects of A. muciniphila in volunteers is currently underway at the University of Louvain. Published on 27/04/2018 A-Mansia Biotech has raised €13M in Series A financing led by Seventure Partners. The […] September 27, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 26 Sep 2018 Spanish Biotech Raises €21.3M To Advance Rare Disease Pipeline Rare genetic diseases in the central nervous system may be less of a headache in future, as Barcelona-based biotech Minoryx has raised €21.3M in series B fundraising to test its lead drug candidate against other rare neurological conditions. According to Philippe Monteyne, partner at investor Fund+, “it is the largest investment in biotech in Spain […] September 26, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 26 Sep 2018 Fish Oils Finally Reel in Positive Results for Cardiovascular Disease Purified fish oil can reduce patients’ risks for adverse cardiovascular events by 25%, according to US-Irish Biotech Amarin’s Phase III trial results. The treatment, called Vascepa, significantly reduced the risk of strokes, heart attacks, and death. It also had a good safety profile in the over 8,000 enrolled patients, who were already taking statins. These […] September 26, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 24 Sep 2018 Gene Therapy Improves Eyesight of Patients With Inherited Blindness UK startup Nightstar Therapeutics has reported good safety and early signs of visual improvements in a Phase I/II trial with a gene therapy for a rare form of inherited blindness. One month after being treated with Nightstar’s gene therapy, five of the 18 patients enrolled in the trial have already shown improvements in their vision. […] September 24, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 22 Sep 2018 Art Made With Kombucha Explores the Science of the Microbiome Artist Alanna Lynch uses kombucha as an art medium to explore our relationship with the microbiome, which is now in the spotlight of human health. An ancient drink made of fermented tea, kombucha is now, over 2,000 years later, exploding in popularity. This week, Coca-Cola acquired an Australian kombucha company in an aim to enter […] September 22, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 20 Sep 2018 RNA Therapy Shows Promise for Treating Liver Cancer British biotech MiNA Therapeutics’ innovative RNA treatment may enhance liver cancer patients’ response to standard cancer therapies, suggest early results from a Phase I/IIa clinical trial. When they received the biotech’s small activating RNA (saRNA) treatment, two patients showed complete responses after being given the cancer treatment sorafenib and one showed a partial response to […] September 20, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 18 Sep 2018 Cockle Molecules Could Help Fight Cancer As you eat your plate of delicious cockles, spare a thought for how their sugars might help to tackle cancer, suggest researchers from the University of Salford, UK. Testing cockle-derived sugars on cancer cells in the lab, the research group found that they have a similar anti-cancer effect to many regular chemotherapy drugs, but with […] September 18, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 18 Sep 2018 Update: French Biotech Raises €22M for a Gene Therapy Trial in Retinitis Pigmentosa Update (18/09/2018): Horama has increased the total raised in its Series B fundraising to €22.5M, with the Belgian fund V-Bio Ventures joining the team of investors backing the company. The funds will be mainly directed at developing Horama’s gene therapy for retinitis pigmentosa. Published on 08/10/2017 Horama has raised a second fundraising round that will support […] September 18, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 17 Sep 2018 Brewing Pheromones for Pest Control Harmful pesticides on your food may be less of a worry in the future, as a Danish biotech company has received a €3M investment to market a safer and more eco-friendly form of agricultural pest control: pheromones. The company, BioPhero, has developed an innovative yeast fermentation method for cheaply producing these pheromones on an industrial […] September 17, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 17 Sep 2018 The First ‘Genomic Internet’ Has Been Launched The Russian non-profit Zenome.io has launched today the beta release of the first decentralized ‘genomic internet’, which is expected to make possible the safe storage of large amounts of genetic data. Genomics is one of the largest generators of data on the internet, more than Twitter and YouTube according to Zenome. Using a decentralized network […] September 17, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 14 Sep 2018 Novozymes Releases Enzyme That Helps Chickens Better Absorb Food Novozymes has released a new enzyme that breaks down bacterial cell debris in the gut and allows chickens to absorb more nutrients from their food. The Danish industrial biotech giant partnered with the Dutch health and nutrition company DSM to produce the bacterial muramidase enzyme solution, which is called ‘Balancius’. It has an interesting story […] September 14, 2018 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 14 Sep 2018 Cell Therapy Helps Regenerate Difficult Bone Fractures All patients in a clinical trial run by the Belgian company Bone Therapeutics have seen an improvement in the healing of bone fractures that have had problems healing. Six months after receiving a single dose of the cell therapy developed by Bone Therapeutics, all 21 patients in the Phase I/IIa clinical trial met the primary […] September 14, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email